Benefits
Supports joint comfort
In one 14-day double-blind, placebo-controlled trial in 60 adults with self-reported knee discomfort, WOMAC and McGill Pain Questionnaire scores were lower at day 14. At day 7 the pain questionnaire had improved but the WOMAC change did not reach statistical significance. This is a single small, short study, so nothing is known about longer use. Joint pain that is persistent, severe or getting worse should be looked at by a healthcare provider.
Helps maintain healthy inflammation markers
Two short double-blind studies measured blood markers only and reported lower C-reactive protein and some cytokines compared with their starting values. These are laboratory numbers, not symptoms, and no cited study showed that the marker changes made anyone feel or function better.
Boron's role in mineral balance (background, not a tested benefit)
This is background nutrition science about boron in general: boron is involved in how the body handles calcium, magnesium and steroid hormones. None of the studies cited on this page measured bone density, bone markers or anything else about bone, so there is no direct evidence that calcium fructoborate benefits bone.
Supports cardiometabolic markers
The blood-marker studies also tracked total cholesterol, LDL and triglycerides alongside cytokines. Any changes were in lab values, over 30 days or less, in small groups, and no cited study followed heart health over time. These results should not be read as a heart benefit.
Low-dose, plant-mimetic boron source
Delivers boron in a complex resembling the boron-sugar structures found in plants, at an intake similar to what a fruit-rich diet provides. Count this boron toward the adult upper limit of 20 mg of boron a day if you also take other boron-containing supplements.
Mechanism of action
Cytokine modulation
Two short human studies tracked blood markers including CRP, IL-1 beta, IL-6 and MCP-1, and some of these were lower than at the start. That is a hypothesis about how CFB might act, not evidence that it changes any inflammation-related health outcome.
Boron-mediated enzyme support
General boron biology suggests boron interacts with enzymes involved in steroid-hormone metabolism, vitamin D handling and connective-tissue proteins. None of this was measured in the human calcium fructoborate studies cited on this page.
Mineral metabolism
Nutrition research on boron itself suggests it can influence how the kidneys handle calcium and magnesium. This is background on the mineral; the calcium fructoborate studies cited here did not measure mineral balance or bone.
Antioxidant signaling
Laboratory and animal work suggests boron-fructose complexes may affect the body's own antioxidant defenses. Test-tube and animal results do not automatically apply to people, and none of the human studies cited here measured antioxidant status.
Clinical trials
Comparative double-blind, placebo-controlled trial, 110 mg CFB twice daily for 14 days
60 adults with self-reported knee discomfort, not a diagnosed joint disease
By day 14 the CFB group's WOMAC score fell by 13.73 points and the McGill Pain Questionnaire score by 8.9 points, both P<0.0001. At day 7 the WOMAC change was only -5.3 and did not reach statistical significance (P=0.06); only the McGill score did. The trial lasted 14 days in 60 people, so it says something about short-term self-reported discomfort and nothing about longer use.
Double-blind, placebo-controlled trial, 112 mg/day CFB for 30 days
Adults with elevated inflammatory markers
Over 30 days the CFB group's CRP fell about 31%, IL-1 beta about 29% and MCP-1 about 31% compared with their own starting values. This study measured blood markers only. No pain, function or health outcome was recorded, so it does not demonstrate a benefit you would feel.